We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Obalon Therapeutics Inc | NASDAQ:OBLN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.05 | 2.81 | 2.87 | 0 | 01:00:00 |
1.
|
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(VOLUNTARY)
|
Domain Partners VII, L.P.
|
||
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a) [X]
(b) [ ]
|
||
3.
|
SEC USE ONLY
|
|||
4.
|
SOURCE OF FUNDS
|
Not Applicable
|
||
5.
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |
[ ]
|
||
6.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7.
|
SOLE VOTING POWER
|
1,000,933*
|
|
8.
|
SHARED VOTING POWER
|
0
|
||
9.
|
SOLE DISPOSITIVE POWER
|
1,000,933*
|
||
10.
|
SHARED DISPOSITIVE POWER
|
0
|
||
11.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
1,000,933*
|
||
12.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES
|
|||
13.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
9.8%
|
||
14.
|
TYPE OF REPORTING PERSON
|
PN
|
1.
|
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(VOLUNTARY)
|
DP VII Associates, L.P.
|
||
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a) [X]
(b) [ ]
|
||
3.
|
SEC USE ONLY
|
|||
4.
|
SOURCE OF FUNDS
|
Not Applicable
|
||
5.
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |
[ ]
|
||
6.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7.
|
SOLE VOTING POWER
|
4,957
|
|
8.
|
SHARED VOTING POWER
|
0
|
||
9.
|
SOLE DISPOSITIVE POWER
|
4,957
|
||
10.
|
SHARED DISPOSITIVE POWER
|
0
|
||
11.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
4,957
|
||
12.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES
|
|||
13.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
Less than 0.1%
|
||
14.
|
TYPE OF REPORTING PERSON
|
PN
|
DOMAIN PARTNERS VII, L.P.
|
|||
By:
|
One Palmer Square Associates VII, LLC, General Partner
|
||
By:
|
/s/ Lisa A. Kraeutler
|
||
Attorney-in-Fact
|
|||
DP VII ASSOCIATES, L.P.
|
|||
By:
|
One Palmer Square Associates VII, LLC, General Partner
|
||
By:
|
/s/ Lisa A. Kraeutler
|
||
Attorney-in-Fact
|
1 Year Obalon Therapeutics Chart |
1 Month Obalon Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions